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Abstract Plasmodium falciparum parasites grew normally in
glutathione (GSH)-depleted normal and G6PD-deficient (Med-
iterranean variant) erythrocytes (RBC). Growth inhibition was
observed only at less than approximately 6^12% residual GSH.
Parasites studied separately with the Sendai virus technique
synthesized GSH de novo and regenerated reduced GSH 10^20
times faster than non-parasitized RBC. Electron spin resonance
measurement of Tempol reduction indicated that the ability to
reduce free radicals was restricted to the parasite. The marked
efflux of oxidized GSH was mainly derived from the parasite. In
conclusion, parasites are endowed with powerful and host-
independent mechanisms which de novo synthesize or regenerate
GSH and allow undisturbed parasite development in GSH-
depleted RBC.
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1. Introduction
Reduced glutathione (GSH) plays important roles in Plas-
modium falciparum-parasitized erythrocytes (RBC): it protects
host RBC against oxidant stress [1,2], modulates parasite-in-
duced RBC membrane modi¢cations and heme catabolism
[3,4], and seems to a¡ect parasite growth [5,6]. Parasite
growth has been reported in some studies to be inhibited in
RBC mutants with low GSH levels, such as in glucose-6-phos-
phate dehydrogenase (G6PD)-de¢cient RBC [5^8], while in
other studies parasite growth appeared to be normal in
G6PD-de¢cient RBC [5,9]. Growth inhibition data [5,9], and
results by Roth et al. [10] showing that GSH was extremely
low in parasitized G6PD-de¢cient RBC, seemed to imply that
parasite GSH was dependent on the host’s glutathione system.
In view of the importance of GSH for both parasite and
host cell, and in front of the above controversies, we analyze
here the separate contributions of host and parasite to GSH
homeostasis. At variance with previous reports [5,9,10], we
show that parasite growth is vastly independent of GSH levels
in the host cell. We also show that the parasite is endowed
with a powerful GSH-synthesizing and GSH-regenerating sys-
tem both independent of host cell metabolism.
2. Materials and methods
2.1. Materials
Culture media, diazenedicarboxylic acid bis(N,N-dimethylamide)
(diamide), 5,5P-dithiobis-2-nitrobenzoic acid (DTNB), 1-chloro-2,4-di-
nitrobenzene (CDNB), NADPH, GSH and glutathione reductase
were from Sigma; [1-14C]glycine (0.2 mCi/ml) was from Amersham;
Percoll was from Pharmacia; monobromobimane was from Calbio-
chem; Di¡-Quik parasite stain was from Baxter Dade AG, Dudingen,
Switzerland; 2,2,6,6-tetramethylpiperidin-1-oxyl-4-ol (Tempol) was
prepared according to [11]; Sendai virus was a kind gift of Prof. H.
Ginsburg, Jerusalem. All other reagents were purchased from com-
mon commercial sources.
2.2. Parasite culture and cell treatments
G6PD-de¢cient and normal RBC were isolated from freshly drawn
blood of healthy, non-hemolytic males of Sardinian origin (Sassari
province), hemizygous for G6PD de¢ciency (Mediterranean variant
with 1^3% residual G6PD activity), and of normal age-matched
male controls, respectively. De¢cient and normal RBC were parasi-
tized with P. falciparum strain FCR-3 and kept in continuous culture
according to Trager and Jensen [12]. Malaria cultures were free of
mycoplasma contamination as checked by PCR assay as indicated
[13]. Trophozoite-stage-parasitized RBC (P-RBC) were isolated from
non-synchronized cultures by Percoll gradient [14]. To assess total
parasitemia and the relative contributions of ring-stage- and tropho-
zoite-stage-parasitized RBC, slides were prepared from cultures 14^
18 h (ring stage) and 34^38 h (trophozoite stage) after inoculation,
stained with Di¡-Quik parasite stain and 400^1000 cells examined
microscopically. Signi¢cance of di¡erences in parasitemia between
normal and de¢cient parasitized RBC was assessed by t-test for paired
samples.
2.3. Depletion and regeneration of GSH
GSH was depleted before inoculation by oxidation with diamide
[15] or by alkylation with CDNB treatment [16]. Diamide (0.1^0.5
mM) and CDNB (0.5^2.0 mM) were added to RBC suspensions
(1% hematocrit) for 5 min at 4‡C or 15 min at room temperature,
respectively. After treatment, RBC were washed 4 or 6 times with a
30-fold excess of phosphate-bu¡ered saline with 10 mM glucose at pH
7.4 (PBS-G), respectively, and parasite inoculation performed as in-
dicated [17]. GSH regeneration studies were performed with washed
RBC, P-RBC and isolated parasites (see Section 2.4) incubated with
or without 0.1 mM diamide at 109 cells/ml in PBS-G for 5 min at 4‡C.
Thereafter cells were sedimented with a refrigerated microcentrifuge
and resuspended to the original cell number with pre-warmed (37‡C)
PBS-G. Samples were taken time-dependently and GSH measured as
described [18].
2.4. Measurement of overall GSH levels and compartment analysis
of GSH
Overall GSH levels were measured in washed non-parasitized RBC
and P-RBC as indicated [18]. GSH was also measured separately in
the host and parasite compartments after permeabilization of the
RBC membrane by Sendai virus treatment. Sendai virus speci¢cally
lyses RBC membrane causing e¥ux of intracellular molecules with a
molecular mass lower than approximately 50 000 Da, but leaves the
parasite membrane intact [19]. P-RBC (trophozoite stage) were incu-
bated at 109 cells/ml in PBS-G supplemented or not with 10 Wl Sendai
virus solution, containing 40^100 Wg virus protein/ml, equivalent to
800^1200 hemagglutination units for 20 min at 37‡C. Thereafter cells
were sedimented with a refrigerated microcentrifuge and GSH was
assayed in the supernatant (host cytosol compartment) and in the
pellet (parasite compartment) as described [18]. The pellet of Sendai
virus-treated non-parasitized RBC was totally devoid of GSH (not
shown). Measurement of overall GSH levels and GSH compartment
analysis was also performed in GSH-depleted P-RBC. Before infec-
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tion with the parasite, RBC were treated or not with 1.5 mM CDNB.
The treatment irreversibly alkylated approximately 85^88% of total
glutathione without impairing parasite growth (see Section 2.3). After
infection, P-RBC (trophozoite stage) were treated or not with Sendai
virus and compartment analysis performed as described above.
2.5. Measurement of oxidized glutathione (GSSG) e¥ux
GSSG e¥ux from RBC through a speci¢c transport system is gra-
dient-dependent [20] and, therefore, maximized by GSH oxidation
produced by diamide treatment. Washed RBC, P-RBC and isolated
parasites were incubated at 109 cells/ml in PBS-G supplemented or
not with 0.1^0.5 mM diamide for 20 min at 37‡C. GSH-depleted cells
were sedimented at selected time points with a refrigerated microcen-
trifuge and GSSG e¥ux rate measured by assaying GSSG in the
collected supernatants as described [21].
2.6. Measurement of de novo GSH synthesis
Washed RBC, P-RBC and isolated parasites were incubated at 108
cells/ml in PBS-G supplemented or not with [1-14C]glycine (2 WCi/ml)
for 3 h at 37‡C. Thereafter cells were supplemented or not with 1 mM
diamide for 5 min at 4‡C and washed twice with PBS-G. Resuspended
cells were then incubated in PBS-G supplemented or not with [1-
14C]glycine (2 WCi/ml) for 2 h at 37‡C. Thereafter GSH was extracted
as described [18] and labeled with monobromobimane (8 mM ¢nal)
for 2 h at room temperature in the dark. The resulting £uorescent
GSH-bimane adduct was separated by HPLC [22] and quanti¢ed us-
ing authentic GSH-bimane adduct as a standard. The incorporation
of [1-14C]glycine in GSH was determined by measuring the radioac-
tivity of the peak containing the GSH-bimane adduct.
2.7. Electron spin resonance (ESR) measurement of Tempol reduction
Washed RBC, P-RBC and isolated parasites were incubated at 109
cells/ml in PBS-G supplemented or not with 0.1 mM Tempol. First-
rate constants of Tempol reduction were calculated from the decay of
ESR signal as described [11]. ESR spectra were recorded on a Bruker
220D equipped with a variable temperature accessory.
3. Results
3.1. Growth of malaria parasites in GSH-depleted RBC
Dependence of the growth of malaria parasites on GSH
levels was studied with GSH-depleted P-RBC. GSH was irre-
versibly depleted by two di¡erent treatments performed before
RBC infection. GSH was speci¢cally alkylated by CDNB [16]
in normal RBC, or oxidized by diamide [15] in G6PD-de¢-
cient RBC, which were unable to reduce oxidized glutathione
during the incubation time (not shown). Table 1 shows that
depletion of GSH by alkylation with CDNB to approximately
12% residual GSH did not signi¢cantly inhibit parasite growth
in normal RBC. Only complete alkylation of GSH inhibited
parasite growth (not shown), probably because CDNB doses
higher than 2 mM caused consistent RBC damage [23] and
lysis, and could therefore be toxic to the parasite as well. In
G6PD-de¢cient P-RBC, extensive irreversible oxidation of
GSH by diamide down to approximately 6% residual GSH
did not signi¢cantly a¡ect parasite growth.
3.2. Overall GSH levels and compartment analysis of GSH
As shown in Table 2, the overall level of GSH was dimin-
ished by approximately 63% in P-RBC compared to non-par-
asitized controls. GSH was measured separately in the host
and parasite compartment after permeabilization of the RBC
membrane by Sendai virus treatment. The GSH level was only
apparently higher in the parasite compartment (633 þ 138 vs.
166 þ 57 nmol/1010 cells). In fact, taking into account the rel-
ative volume occupied by trophozoites (approximately 80% of
total cellular volume in P-RBC), the distribution of GSH
appears to be homogeneous in the host and parasite compart-
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Table 1
Parasite growth in GSH-depleted normal and G6PD-de¢cient RBC
GSH at inoculum (% of control) Parasitemia
Ring stage 24 h) Trophozoite stage (48 h)
Normal RBC
0.5 mM CDNB 71 þ 15 115 þ 34 104 þ 24
1 mM CDNB 28 þ 8 124 þ 29 103 þ 20
1.5 mM CDNB 12 þ 5 105 þ 22 80 þ 28
G6PD-de¢cient RBC
0.5 mM diamide 6 þ 4 78 þ 37 90 þ 5
GSH was depleted by treating normal and G6PD-de¢cient RBC with CDNB and diamide, respectively. GSH-depleted and control RBC were
subsequently utilized for malaria culture. GSH values are percent values of control levels measured in normal or G6PD-de¢cient RBC before
depleting treatments. Control GSH levels were 1950 þ 320 nmol/1010 cells (normal RBC) and 1430 þ 180 (G6PD-de¢cient RBC) (mean þ S.D. of
triplicate experiments). Parasitemias are percent values of control parasitemias measured in normal or G6PD-de¢cient RBC at the ring or
trophozoite stage. Control parasitemias were 3.8 þ 0.7% parasitized RBC (ring stage) and 3.1 þ 0.5% parasitized RBC (trophozoite stage) after
inoculation (mean þ S.D. of triplicate experiments). Di¡erences in parasitemias measured in control and GSH-depleted RBC were never signi¢cant.
Fig. 1. GSH regeneration in non-parasitized RBC (RBC), parasi-
tized RBC (P-RBC) and isolated parasites (IP) after GSH oxidation
by diamide (0.1 mM ¢nal) treatment. Values are expressed as per-
cent of the respective basal GSH levels measured before diamide
treatment. Mean values of triplicate experiments.
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ments. GSH analysis was also performed in GSH-depleted
RBC. Treatment of RBC with CDNB (1.5 mM ¢nal) before
parasite inoculation irreversibly alkylated approximately 85%
of total GSH (Table 2). CDNB-treated RBC supported nor-
mal parasite development (see Section 3.1) and showed ap-
proximately 40% increase in overall GSH level at trophozoite
stage. Since no measurable regeneration of GSH was observed
in CDNB-treated non-parasitized RBC after 34^38 h incuba-
tion, parasites were evidently able to synthesize GSH. Com-
partment analysis indicated a homogeneous distribution of
GSH also in CDNB-treated P-RBC.
3.3. GSH regeneration and de novo synthesis in malaria
parasite
As shown in Fig. 1, isolated parasites were able to regener-
ate GSH at a very fast rate: less than 2 min was necessary to
essentially restore basal GSH levels. P-RBC showed a rate of
GSH regeneration very similar to that observed in isolated
parasites. RBC regenerated GSH at a much lower rate and
approximately 20 min was necessary to restore the basal GSH
levels. These data indicate that isolated parasites possess e⁄-
cient mechanisms to regenerate GSH and that the GSH-re-
generating activity in P-RBC is mainly due to the parasite
contribution.
To test the ability of P-RBC to utilize their GSH to metab-
olize oxidant species we monitored their capability to reduce
Tempol, a membrane-permeable mild oxidant which becomes
non-reactive upon enzymatic coupling to intracellular GSH
[11]. Using ESR measurement, ¢rst-rate constants (KT) of
Tempol regeneration were observed in all conditions consid-
ered. KT was 0.061 þ 0.012 in control RBC, 0.022 þ 0.0025 in
P-RBC and 0.019 þ 0.0037 in isolated parasites (mean val-
ues þ S.D., n = 3). KT was almost identical in P-RBC and
isolated parasites, con¢rming that the ability to reduce oxi-
dant species appears to be limited to the parasite. Moreover,
the ¢rst-order kinetics of Tempol decay indicates that para-
sites were able to keep constant GSH levels during the exper-
imental period even under moderate oxidant stress.
In addition to fast GSH regeneration, the parasites were
endowed with powerful de novo GSH synthesizing ability.
Fig. 2 shows that P-RBC and isolated parasites, but not
RBC, displayed a remarkable GSH synthetic activity even in
the absence of oxidative treatment by diamide. Diamide treat-
ment strongly stimulated de novo synthesis in RBC but had
no e¡ect in P-RBC and isolated parasites.
3.4. E¥ux of GSSG from P-RBC and isolated parasites
GSSG permeates across the RBC membrane through a spe-
ci¢c channel and GSSG e¥ux is maximized upon extensive
oxidation of GSH [20]. The relatively low level of GSH in P-
RBC and in isolated parasites in the presence of intense de
novo GSH synthesis may suggest GSSG e¥ux from P-RBC.
Indeed, the e¥ux rate of GSSG from untreated P-RBC and
isolated parasites was much higher than from control RBC
(see Fig. 3). To test whether RBC membrane was a rate-limit-
ing step for GSSG e¥ux from P-RBC, GSH was extensively
oxidized by diamide treatment. While GSSG e¥ux rate from
P-RBC was not in£uenced by diamide treatment, diamide-
treated isolated parasites showed a 2^4-fold GSSG e¥ux
rate compared to diamide-treated P-RBC (Fig. 3).
4. Discussion
In this work we show normal growth of P. falciparum in
GSH-depleted normal and G6PD-de¢cient (Mediterranean
variant) RBC. Impairment of parasite growth was observed
only below approximately 6^12% residual GSH. The ability of
malaria parasites to grow in GSH-depleted RBC was evi-
dently connected with the existence of an autonomous and
e⁄cient glutathione system independent of host metabolism.
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Fig. 2. De novo GSH synthesis in non-parasitized RBC (RBC), par-
asitized RBC (P-RBC) and isolated parasites (IP) in basal condi-
tions and after GSH oxidation by diamide treatment. GSH synthesis
is expressed as nmol of incorporated [14C]glycine/1010 cells/h. Mean
values þ S.D. of triplicate experiments. Bars indicate standard devia-
tion.
Table 2
Overall GSH levels in RBC and P-RBC, and compartment analysis of GSH in P-RBC
Treatment Overall levels Compartment analysis
RBC P-RBC Parasite RBC
None 1822 þ 220 681 þ 152 166 þ 57 633 þ 138
CDNB (1.5 mM) 282 þ 87 459 þ 119 110 þ 41 307 þ 76
Overall levels of GSH were measured in intact RBC and P-RBC treated or not with CDNB (1.5 mM ¢nal) before parasite infection. Compartment
analysis of GSH was performed in isolated parasites (parasite compartment) and host RBC cytosol (RBC compartment) from Sendai virus-treated
P-RBC, treated or not with CDNB (1.5 mM ¢nal) before parasite infection. GSH levels are expressed as nmol GSH/1010cells. Mean values þ S.D.
of triplicate experiments.
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The parasite was indeed capable of de novo GSH synthesis at
a high rate, and was able to extensively regenerate GSH in less
than 2 min, compared to 20 min required by non-parasitized
RBC.
Here we also show that the parasite membrane was highly
permeable to GSSG, compared to the membrane of parasi-
tized or non-parasitized RBC. Thus, the host cytoplasm be-
haves as a sink for parasite GSSG, potentially available for
back-reduction to GSH by NADPH-dependent glutathione
reductase of the host. Parasite-produced GSSG is expected
to pose a critical oxidative stress to G6PD-de¢cient RBC,
by competing with endogenous GSSG for NADPH, insu⁄-
ciently provided by the low residual G6PD activity.
The glutathione system in malaria and the relationship be-
tween GSH and parasite growth have been the object of sev-
eral studies (for review, see [2]). Most studies indicated im-
paired parasite growth in GSH-oxidized or G6PD-de¢cient
RBC characterized by low levels of GSH and an impaired
capacity to reduce GSSG [5^8]. Our data are at variance
with those studies and agree with the no-di¡erence data by
Pasvol and Wilson [9] and Fritsch et al. [24]. Studies showing
impaired growth in G6PD-de¢cient RBC [5^8] were per-
formed with the candle-jar method [12], where a burning can-
dle was used to lower oxygen tension in the airtight incubator.
Toxic fumes from the extinguishing candle may preferentially
upset the more delicate de¢cient RBC and possibly explain the
discrepancy. Low levels of GSH have been described in P.
falciparum P-RBC by others [25], where high GSH levels
had been described previously in parasitized RBC in murine
malaria [26] and increased stability of GSH remarked by Roth
et al. [27] in P. falciparum-parasitized RBC. Various interpre-
tations were o¡ered for the ‘unexpected’ [27] result, but no
clear evidence was provided for a de novo synthetic ability of
the isolated parasite, shown here for the ¢rst time.
The present results are of interest in two respects. First,
they indicate that the parasite is independently endowed
with highly e⁄cient anti-oxidant mechanisms capable of de
novo synthesis of GSH, and GSH regeneration through para-
site-encoded G6PD [28] and glutathione reductase [29]. As a
consequence, the parasite is a well-protected target for oxidant
drugs. Only oxidants targeted to speci¢c parasite components
are able to destroy the parasite at acceptably low concentra-
tions. One good example is artemisinin, a stable endoperoxide
that binds to and is activated by the clustered heme of ma-
larial pigment hemozoin [30].
Secondly, the present results suggest that non-parasite-tar-
geted oxidants may not be e¡ective as direct parasite killers.
Instead, the combined oxidant stress provided by the parasite
and by the exogenous oxidant, unable to impair the develop-
ment of parasite, may nevertheless target the parasitized RBC
for destruction by the macrophage system of the host. This
indirect parasite killing mechanism is particularly e¡ective in
parasitized G6PD-de¢cient RBC, where enhanced phagocytic
removal of ring-parasitized, G6PD-de¢cient RBC has been
observed (Cappadoro et al., unpublished results). Selective
removal of parasitized G6PD-de¢cient RBC may explain old-
er data by Luzzatto et al. [31] showing a much higher fre-
quency of circulating parasitized G6PD-normal RBC com-
pared to parasitized G6PD-de¢cient RBC in heterozygotes
that carry a double population of normal and de¢cient RBC
in their blood.
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